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PHILOSOPHY OF BIOLOGY
Characterizing causality in
cancer
Abstract Philosophers have explored the concept of causality for centuries. Here we argue that ideas
about causality from philosophy can help scientists to better understand how cancerous tumors grow
and spread in the body. After outlining six characteristics of causality that are relevant to cancer, we
emphasize the importance of feedback loops and interactions between tumor-cell-intrinsic and
tumor-cell-extrinsic factors for explaining the formation and dissemination of tumors.
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Introduction
’W
hat causes cancer?’ is perhaps the
central question in cancer
research. This question can be
understood in various ways, including mechanis-
tically (how does a tumor grow and spread
within an organism?) and etiologically (what are
the factors that initiate and favor cancer devel-
opment?). In this article we focus on mechanistic
questions, combining philosophical and biologi-
cal insights to identify six key characteristics that
can be used to explore causality in the context
of cancer. We will not discuss etiological ques-
tions, though these remain of interest to philoso-
phers working on biology and medicine (see, for
example, Vineis et al., 2017).
Philosophy of science has a long tradition of
investigating the different aspects of causality,
including causal inference, probability, counter-
factuals and manipulability (Woodward, 2003).
Here, we build on this work – especially on cases
in which philosophical analyses have been
applied to cancer (Bertolaso, 2011; Plutyn-
ski, 2018) – to revisit the question ’what causes
cancer?’ in terms of the following six
characteristics:
Multicausality: many different factors influ-
ence cancer initiation and dissemination.
Causal variability: the factors that influence
the formation and dissemination of tumors
can vary significantly according to tumor
type, local context, level of analysis, and the
unique history of each tumor.
Causal necessity and/or sufficiency: some
factors may, by themselves, be sufficient to
influence cancer initiation and dissemination,
or they may be just one factor among many.
(Indeed, it is now recognized that most can-
cers result from a combination of factors).
Causal intricacy: the factors that influence
the formation and dissemination of tumors
interact in complex ways, so much so that it is
difficult to attribute a specific causal role to a
given factor.
Sequence-dependent causality: cancer is an
evolving process, with different factors having
different roles at different stages.
Spatially-situated causality: factors may
operate within the tumor microenvironment,
or they may operate from a distance. Because
we aim to identify where and when to inter-
vene in order to prevent the disease (Wood-
ward, 2003), clarifying the spatial location of
causal factors is crucial (Laplane et al.,
2018; Laplane et al., 2019).
In what follows we will first consider causality
in the formation of tumors, and then go on to dis-
cuss causality in the dissemination of tumors. Two
main points will stand out. First, despite a fre-
quent focus on tumor-cell-intrinsic factors, in
many cases it is the interaction between the
intrinsic and the extrinsic factors that is impor-
tant. Second, although it might seem natural to
equate the causality of cancer with its
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temporal sequence (that is, with the different
steps of cancer progression), it will in fact be nec-
essary to distinguish causality from sequence
because of the presence of feedback loops and
because some causal connections might go
’backwards’.
Causality in tumor formation
There are two main explanatory schemes for
tumor formation (Figure 1): a tumor-cell-centric
view, starting with an event within the cell which
initiates an avalanche of secondary events; and a
tumor environment-centric view, which empha-
sizes the multiplicity of interactions in the tumor
environment and the reversibility of many can-
cer-related events. Here we examine two theo-
retical frameworks for these two views.
In the somatic mutation theory, which centers
on the tumor cells, the default state of a cell is
quiescence, and a tumor forms as a result of
genetic mutations in a single cell
(Stratton et al., 2009). In this theory, causality is
due to a single factor, and causal variability
exists because different oncogenic drivers may
be found in different tissues. A good example is
the onset of hematological malignancies such as
chronic myelogenous leukemia, with the produc-
tion of an aberrant BCR-ABL fusion protein. In
the somatic mutation theory, sequence-depen-
dent causality and causal intricacy have minimal
roles, and distant causality does not have any
role. However, the introduction of sequences of
mutations (such as those seen in multistage car-
cinogenesis) can increase the causal complexity
associated with this theory.
The tissue organization field theory, on the
other hand, centers on the tumor environment.
This theory involves multiple causalities at vari-
ous levels, as well as causal variability, causal
intricacy, sequence-dependent causality and
spatially-situated causality (Soto and Sonnen-
schein, 2011). The disruption of tissue architec-
ture is the critical causal event in this theory,
while mutations (which are randomly distrib-
uted), are a consequence of this disruption.
Although these two theories have their
strengths and weaknesses, we believe that
recent work tends to support the tissue organi-
zation field theory more than the somatic muta-
tion theory, at least for some cancers. In
pancreatic cancer, for example, it has been
shown that tissue architecture plays a decisive
role in modulating the phenotypes of tumor cells
(Ligorio et al., 2019). Furthermore, cancer-asso-
ciated driver mutations are distributed in most
of the organs that are perfectly normal
(Yizhak et al., 2019). Other examples include
the way interactions between the tumor, its
microenvironment and the immune system have
a key role in cancer progression, and the way
tumor vascularization is critical for awakening
dormant tumors and for tumor expansion. Evi-
dence is also emerging for causal interactions
between the tumor and its broader ’organismal
environment’, such as the microbiota or the cen-
tral nervous system (Laplane et al., 2019). How-
ever, the tissue organization field theory also
makes a causal connection between the disrup-
tion of the tissue architecture and mutations in
the tumor cells, a concept that is debatable inso-
far as mutations may also occur randomly.
Causality in tumor dissemination
Tumor dissemination is a multistep process that
involves the passage of tumor cells from the pri-
mary site to metastatic sites located in one or
more distant organs. It is characterized by the fol-
lowing events (Figure 2): i) exit from the primary
tumor, ii) circulation through the bloodstream or
lymphatic system, and iii) colonization of the met-
astatic site (if the cells settle there). A compre-
hensive understanding of all these steps – which
involve interactions between various tumor-cell-
intrinsic and tumor-cell-extrinsic factors – is cru-
cial to the design of more efficient therapies.
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Figure 1. Two theories of tumor formation. In the somatic mutation theory (SMT; left) the
default state of the cell is quiescence, and a genetic event in the cell triggers a
unidirectional, irreversible and deterministic process that leads to tumor expansion and
dissemination. In the tissue organization field theory (TOFT; right), the default state of the
cell is proliferation, and a disruption of the tissue architecture leads to the diffusion of
various mutations within the tumor and to the activation of the tumor microenvironment
(TME). Through feedback mechanisms, this leads to further disruption of the tissue
architecture, which promotes tumor expansion and dissemination.
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Historically, Paget’s ’seed and soil’ metaphor
has been used to describe how dissemination
results from favorable interactions between cir-
culating tumor cells (the seed) and the specific
microenvironments they encounter (the soil).
This analogy is still used today, although we
know much more about what happens at the cel-
lular and molecular levels (Langley and Fidler,
2011). Here we discuss causality during the
three stages of dissemination, and show how
some or all of the six characteristics mentioned
above are involved.
Exit from the primary tumor
Different causal factors, both intrinsic and extrin-
sic to the tumor cell, are involved in the two pro-
cesses that make up this step – the detachment
of cancer cells from the tumor, and their journey
towards an accessible blood or lymph vessel
(which, depending on the size and vasculariza-
tion of the primary tumor, may require invasion
of the surrounding tissue, also known as local or
loco-regional invasion). In particular, the epithe-
lial-to-mesenchymal transition (EMT) enables
cancer cells to lose intercellular adherence and
acquire the mesenchymal properties that foster
local invasion and migration. Other tumor-cell-
intrinsic mechanisms are involved, such as aber-
rant intracellular signaling (e.g., EGFR amplifica-
tion or truncation), the loss of adhesion
molecules (such as E-cadherin), the expression of
transcription factors that regulate the transition,
and the production of proteins that degrade the
extracellular matrix.
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Figure 2. The influence of tumor-cell-intrinsic and tumor-cell-extrinsic factors on tumor formation and the dissemination of tumor cells. The main
steps in the progression of cancer (carcinogenesis and the three steps of dissemination) are shown in the center panels, along with the key tumor-cell-
intrinsic factors (top; blue text) and tumor-cell-extrinsic factors (bottom; grey text) that influence progression. We will use step 2 of dissemination to
explain the different types of causal relationships proposed in the figure. An example of an intrinsic factor acting at a given step (a type ’a’ event) is the
formation of clusters of tumor cells to enhance migration efficiency (2a, top), and an example of an extrinsic factor is the protection provided by
vascular elements against immune attack and physical stress, during the same step (2a, bottom). Events during a given step can also exert an influence
on a later step (type ’b’ events): for instance, the initiation of the epithelial-to-mesenchymal transition (EMT) during step 1 of dissemination triggers the
possibility of long-distance circulation in step 2 (2b, top). Events during a given step can also exert an influence on an earlier step (type ’c’ events): for
instance, the elements in the secondary tumor microenvironment (TME), which are part of step 3 of dissemination, also act as attractors for cancer cells
during step 2 (2c, bottom). PMN: pre-metastatic niche.
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Tumor-cell-extrinsic factors are also crucial for
local invasion (Quail and Joyce, 2013). For
instance, stromal cells produce pro-migratory
factors that are required for tumor cell motility
and for remodeling the extracellular matrix, as
well as a signaling molecule called TGF-b (trans-
forming growth factor beta) that stimulates the
EMT. Conversely, interactions between stromal
cells and cancer cells undergoing the EMT may
influence the phenotypic and functional features
of immune cells (Chockley and Keshamouni,
2016). This illustrates causal intricacy, and more
specifically here, a reciprocity between two
types of causal actors in invasion.
Local invasion also displays characteristics of
causal necessity and/or sufficiency and
sequence-dependent causality. For instance, the
effects of TGF-b on cancer progression are
highly dose-dependent and they may vary from
step to step: for example, TGF-b can act as a
tumor suppressor in one step, and then help to
stimulate the EMT in a later step (Bachman and
Park, 2005). Moreover, some epithelial cells can
enter the circulation without undergoing an
EMT: this is possible due to the phenomena of
clustered migration (where transitioned and non-
transitioned cells move together) and the
remodeling of the primary microenvironment by
mesenchymal cells. This means that the EMT
may be considered permissive rather than neces-
sary for metastasis (Jolly et al., 2017).
Circulation
To enter the bloodstream or the lymphatic sys-
tem – a process known as intravasation – a can-
cer cell must cross an endothelial barrier. Again,
this involves both tumor-cell-intrinsic factors
(such as the expression of adhesion molecules
and permeability factors) and tumor-cell-extrin-
sic factors (such as interactions with myeloid cells
and endothelial cells, or feedback loops involv-
ing small signaling molecules called cytokines;
Su et al., 2014). An instance of causal intricacy
here is the fact that the tumor vasculature can
undergo its own EMT (called an endoEMT) and
favor the transmigration of tumor cells into the
circulation by disrupting the endothelial cell bar-
rier during intravasation.
Once in the bloodstream, the survival of cir-
culating tumor cells, their arrest in the capillar-
ies, and their extravasation into the metastatic
tissues, depend on the intrinsic properties of the
cells (such as resistance to anoı¨kis and their abil-
ity to avoid immune surveillance) and on various
aspects of their local environment (Strilic and
Offermanns, 2017). The cells can, for example,
protect themselves by forming clusters, which
may be homotypic (i.e., exclusively composed of
tumor cells) or heterotypic (i.e., they can also
contain neutrophils, myeloid suppressor cells or
platelets; Szczerba et al., 2019).
When metastatic cells reach the vessels at the
secondary site, their exit from the circulation
relies on both intrinsic changes (such as the
reversal of the EMT for cells that have transi-
tioned) and extrinsic factors (such as another
EndoEMT, this time linked to tumor cell extrava-
sation). Neutrophil extracellular traps also have
an important role in removing tumor cells so
that they can undergo extravasation (Cools-
Lartigue et al., 2013), as does the nature of the
surface molecules expressed by endothelial cells
at the metastatic sites.
Colonization of the metastatic site
The successful colonization of a secondary site
depends on the early establishment of a ’pre-
metastatic niche’ (i.e., a local environment that is
favorable to the seeding of circulating cancer
cells). Again, both tumor-cell-intrinsic factors
(such as cytokines and exosomes derived from
the primary tumor; Tung et al., 2019) and
tumor-cell-extrinsic factors (e.g., subsets of cells
derived from the bone marrow; Gao et al.,
2019) are involved. Moreover, the types of
causal explanations for site-specific seeding are
multiple and diverse. Some organs (such as the
growth factor–enriched bone microenvironment)
may manifest a certain predisposition for wel-
coming tumor cells. Other metastases rely
mainly on specific organ chemokines binding to
cancer cell receptors (such as CXCL12 binding
to CXCR4; see also Liotta, 2001). Recent
research also suggests that organ-specific angio-
crine signaling from endothelial cells may be an
important site-specific mechanism for
metastasis.
In addition, the facilitating role of pro-coloni-
zation factors may be attributed to both tumor-
cell-extrinsic factors (such as immune cells of the
pre-metastatic niche) and the cancer cells them-
selves. Indeed, metastatic cancer cells may
cooperate with early migrating cells, whose
’inefficient’ seeding could nevertheless create
conditions that are more favorable for later
waves of cells (Bidard et al., 2008).
Organ colonization by cancer cells can lead
to two different fates: tumor expansion, or a
period of dormancy followed by reactivation.
Tumor expansion at a secondary site requires
many interactions that are similar to those
required for primary tumor growth, though
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these interactions are adapted to the new envi-
ronment. Moreover, cross-talk between different
metastatic sites may influence the development
of secondary tumors.
Cancer cells and tumor-cell-extrinsic factors
can also travel between the different environ-
ments involved in metastasis. It is likely that can-
cer cells leave the primary tissue early in tumor
development, and that they may later migrate
from established metastases in the case of fur-
ther seeding at new sites (Gundem et al., 2015).
Metastatic cells and molecules can also travel
back to the primary site, where they may con-
tribute to continued growth of the primary
tumor, the growth of new blood vessels, and the
recruitment of stromal cells to the tumor
(Kim et al., 2009). This phenomenon is called
’self-seeding’ and, like the feedback loops dis-
cussed previously, is another example of how
the causality involved in cancer is more complex
than suggested by the classic sequential view of
tumor formation and dissemination.
Conclusion
Exploring the multi-dimensional nature of causal-
ity in cancer – especially dimensions that tend to
be neglected, such as sequence-dependent cau-
sality and spatiality-dependent causality – has the
potential to improve our understanding of how
the disease originates, develops and spreads. In
particular, we draw attention to seven points:
i. The explanatory power of conceptual
frameworks: two philosophies of cancer,
the tumor-cell-centric view and the envi-
ronment-centric view, have critically
shaped our physio-pathological under-
standing of cancer (Bissell and Radisky,
2001). Current research could benefit
from a thorough consideration of the
intricacy of these two frameworks and
their complementarity.
ii. The distinction between deterministic
and stochastic causal explanations: while
deterministic explanations may be suffi-
cient in some cases, stochastic explana-
tions will be required in others.
iii. The relative strengths of the various
causes or types of causes involved in can-
cer initiation and dissemination: if hierar-
chies of causal influences could be
established, they could be used to priori-
tize targets for drug discovery research.
iv. The existence of different causal explana-
tions at different stages of the disease:
identifying these different explanations,
and determining if they are connected or
not, will benefit researchers.
v. The organ-specific nature of metastatic
colonization is usually an example of
causal intricacy: in some cases, it will be
possible to identify a single causal expla-
nation, but most cases will require multi-
ple explanations, because they result
from a variety of interacting causes.
vi. The nature of dormancy: how do dor-
mant states differ from the normal physi-
ological state, and how does causality
intervene?
vii. Causalities can be nonlinear: a complete
understanding of cancer is likely to
involve various feedback and feed-for-
ward loops.
A greater awareness of the complexity of
causality will, we strongly believe, lead to a
deeper understanding of the disease by philoso-
phers, scientists and clinicians alike.
Note
This Feature Article is part of the Philosophy of
Biology collection.
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